Private Equity
Chicago-based Project44, an advanced visibility platform for shippers and third-party logistics firms, has secured $45 million in funding. Sapphire Ventures led the round. In conjunction with the funding, Kevin Diestel, a partner at Sapphire Ventures, will join Project44's board of directors.
1 min read · 01 October 2018
Town Hall Ventures has raised $115 million for its new fund, according to an SEC filing. Based in New York City, the firm invests in healthcare solutions for underserved communities.
1 min read · 01 October 2018
Liferay Inc, a software creator, has acquired a controlling stake in Reston, Virginia-based Triblio, an account-based marketing platform. No financial terms were disclosed. Triblio's backers included Longworth Venture Partners and Kepha Partners.
3 min read · 01 October 2018
Toronto-based Thentia, a provider of regulatory and compliance software, has agreed to secure venture debt funding from Espresso Capital. No financial terms were disclosed. WD Capital Markets Inc provided financial advice to Thentia on the deal.
1 min read · 01 October 2018
VelosBio, a biotech firm focused on oncology, has raised $58 million in Series A funding. Arix Bioscience plc and Sofinnova Ventures led the round with participation from other other investors that included Pappas Ventures, Chiesi Ventures, Takeda Ventures Inc and Decheng Capital. In conjunction with the funding, Mark Chin, Arix investment director, will join the VelosBio board of directors.
1 min read · 01 October 2018
Oakland, California-based Modis Therapeutics, a developer of medicines for patients with rare genetic diseases, has raised $30 million in Series A funding. F-Prime Capital Partners and OrbiMed led the round.
1 min read · 01 October 2018
Sequoia Capital formally filed to raise new U.S. venture-capital and growth funds, according a several of documents submitted to the SEC. The Silicon Valley firm did not report targets for the funds or initial closings.
1 min read · 28 September 2018
Emeryville, California-based Gritstone Oncology Inc, a developer of tumor-specific cancer immunotherapies, has raised about $100 million after pricing its IPO of over 6.6 million shares at $15 per share. The stock began trading September 28, 2018 on the NASDAQ under the ticker symbol "GRTS." Goldman Sachs, Cowen and Company LLC and Barclays Capital Inc are the lead underwriters. Gritstone Oncology’s pre-IPO backers included Versant Ventures, The Column Group, Clarus Funds, Frazier Healthcare Partners, RedMile, Casdin Capital, Lilly Asia Ventures, Trinitas Capital, GV, Alexandria Venture Investments and Bay City Capital.
3 min read · 28 September 2018
Shanghai-based CooTek, a global mobile internet company, has raised $52.2 million for its IPO after pricing its 4.35 million shares at $12 per share. The stock began trading September 28, 2018 on the New York Stock Exchange under the ticker symbol "CTK." Credit Suisse Securities (USA) LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Citigroup Global Markets Inc are the lead underwriters. CooTek's pre-IPO backers included Sequoia Capital China, Qiming Venture Partners and New Alliance Capital, according to Crunchbase.
3 min read · 28 September 2018
Oakland, California-based Broadly, a marketing startup focused on helping small businesses generate positive online reviews, has raised $10 million in Series B funding. Foundry Group and Calibrate Ventures led the round with participation from Team Builder Ventures.
1 min read · 28 September 2018
